LipoCoat receives grant for organ-on-chip project
Organ-on-chips’ are small chips with human cells that are useful for e.g. studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body.
LipoCoat and research partners received an € 4.8 million grant for organ-on-chip project. A collective of research groups, companies and knowledge institutions that includes LipoCoat, has the grant from the Dutch Research Council (NWO) for an organ-on-chip project called ‘SMART OoC’. The consortium is working towards a universal standard for the pharmaceutical industry.
‘Organ-on-chips’ are small chips with human cells that are useful for e.g. studying cancerous metastases in the bloodstream or the development of scar tissue, or for testing the effect of drugs or food outside a human body. The consortium’s ultimate goal in the future is to link multiple organ chips together to simulate a whole body.
LipoCoat is presently engaged in a coating project with a strategic partner to demonstrate the application of our coating to a central venous catheter (CVC). An estimated 50% of hospital acquired infections (HAI’s) can be attributed to contaminated catheters. In many cases, bacteria attach to and colonize the surface of the catheter leading to biofilm formation and inevitably to infections.
LipoCoat’s coating can provide a passive and drug-less solution to reduce biofilm formation, improve blood compatibility and prevent tissue damage. Initial results look promising. The coating can be applied successfully and lab tests demonstrate a >95% reduction of bacterial colonization with S. aureus.
Insights Care, a magazine that covers issues and trends shaping the future of the healthcare industry, will publish a cover story on LipoCoat later this month. The full article can already be read here.
More information: www.lipocoat.com